Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Single agent activity of IOI in solid tumours: Renal

Single agent activity of IOI in solid tumours: Renal

en English

Only available as part of a course
Proceed to module  Shortlist  Rate Module  Share

en English

Summary An overview of current clinical research in immunotherapy of renal cancer

This module focuses on the immunogenicity of renal cancer and provides an overview of the current clinical research in immunotherapy for this tumour type.

This module is part of a course; 15 modules providing an up to date resource for medical professionals who seek to understand the latest research, advances in technology and future directions of immuno-oncology.

Published February 2019.

Target Audience

This module is aimed at medical professionals interested in the field of immuno-oncology.

Learning Objectives

By the end of this module you will be able to:

  • Understand the immunogenic nature of renal cancer
  • Describe the immune response of renal cancer observed in clinical trials
  • Be aware of the future directions of research, challenges and gaps in knowledge

This course awards the learner 4 CME points upon successful completion and passing of the assessment.

Only available as part of course(s):

Immuno-oncology: Advances in cancer treatment

IT Requirements

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Commercial Support

Production of this module was funded by an unrestricted grant from Bristol-Myers Squibb Foundation and AbbVie Inc.

Disclosure Policy

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from the Bristol-Myers Squibb Foundation and AbbVie Inc.

Both the BMS Foundation and AbbVie Inc. have had no input in the creation of the e-learning materials including the process of selecting speakers.

For more information, please email education@ecancer.org

Proceed to Module

Relevant to the following professions

  • Oncologist
  • Other
  • Researcher
Proceed to module  Shortlist  Rate Module

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation